4 completed. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Access Pharmaceuticals, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients MuGard, Control Rinse - Oral Mucositis | Phase 4 | Completed | Access Pharmaceuticals, Inc. | 120 | 2011-01-01 | 2013-09-12 |
| 4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies 3 Day Thiarabine, 5 Day Thiarabine - Leukemia | Phase 1 | Completed | M.D. Anderson Cancer Center | 31 | 2010-08-01 | 2014-06-17 |
| Patient Comfort With Vascular Closure Mynx Vascular Closure Device, AngioSeal Vascular Closure Device - Vascular Closure | Not applicable | Completed | University of Florida | 64 | 2009-10-01 | 2011-12-06 |
| Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region amlexanox, Vehicle rinse - Oral Mucositis | Phase 2 | Completed | Access Pharmaceuticals, Inc. | 58 | 2000-02-01 | 2010-03-18 |
Mucositis (2) · Stomatitis (2) · Anemia, Refractory (1) · Blast Crisis (1) · Head and Neck Neoplasms (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Chronic (1) · Neoplasms, Squamous Cell (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
4'-thio-arabinofuranosylcytosine (1) · amlexanox (1)
United States (4)
Dimitrios Papadopoulos, MD (1) · Hagop Kantarjian, MD (1) · J Mocco, MD (1) · Paul Busse, M.D., Ph.D. (1) · William Wisbeck, MD (1)